Health and Medicine
-
June 26, 2014
Rousseau appointed to NIH study group
Vanderbilt researcher Bernard Rousseau, Ph.D., is being appointed to the Motor Function, Speech and Rehabilitation Study Section at the Center for Scientific Review, National Institutes of Health, for the term beginning July 1 and ending June 30, 2020. -
June 26, 2014
Aliyu receives alumnus award from UAB
Muktar Aliyu, M.D., MPH, Dr.P.H., associate director for Research at the Vanderbilt Institute for Global Health, is the recipient of the 2014 Alumnus Award for Scientific Excellence from the University of Alabama at Birmingham School of Public Health. -
June 26, 2014
VU study shows common diabetes drug can slow chronic kidney disease progression
Vanderbilt investigators have demonstrated in two studies that metformin-based treatments delay the onset and progression of chronic kidney disease (CKD) compared with other treatments for diabetes. -
June 26, 2014
VUSM team seeks to hone in on health care ‘hot spots’
Vanderbilt University School of Medicine is fielding one of 10 teams of students selected to participate in a project aimed at identifying the most frequent users of health care. -
June 19, 2014
HPV-positive head and neck cancer patients may receive lower radiation dose
A new study suggests that lowering the dose of radiation therapy for some head and neck cancer patients may improve outcomes and cause fewer long-term side effects. -
June 19, 2014
VICC researchers in spotlight at national cancer conference
New Vanderbilt research suggests patients with advanced melanoma — the most deadly form of skin cancer — could safely benefit from a combination of immunotherapy and targeted therapies aimed at specific gene mutations. -
June 16, 2014
Factor impacts bone toughness
The factor ATF4 has a role in the toughness of bone and its resistance to fracture, suggesting new therapeutic targets.